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Abstract: Chitin and chitosan are natural based non-toxic, 
biodegradable and biocompatible polymers and have been used in 
biomedical areas in the form of sutures, wound healing materials and 
artificial skin, and for the sustained release of drugs as well as in various 
industrial applications. However, practical use of these polymers has 
been mainly confined to the unmodified forms. Recently, there has been 
a growing interest in chemical modification of chitin and chitosan to 
improve their solubility and widen their applications. Among them, 
phosphorylated chitin and chitosan have attracted considerable interest 
because of their various advantages: anti-inflammatory property, ability 
to form metal complexes, blood compatibility and formation of anionic 
polyelectrolyte hydrogels. The purpose of this review is to take a closer 
look of different synthetic methods of phosphorylated chitin and chitosan 
and their potential applications in environmental, food, fuel cell, and 
biomedical fields. Based on current research and existing products, 
some new and futuristic approaches in this context area are discussed.   
 
Introduction 
Chitin, a naturally abundant mucopolysaccharide, and the supporting material of 
invertebrates such as crustaceans, insects, consist of a homopolymer of ȕ (1ĺ 
4) linked 2-acetamido-2-deoxy-ȕ-D-glucose residues. Its immunogenicity is 
exceptionally low, in spite of the presence of nitrogen. It is a highly insoluble 
material resembling cellulose in its solubility and chemical reactivity. Chitosan is 
the N-acetylated derivative of chitin, although this N-deacetylation is almost 
never complete [1, 2]. Chitin and chitosan are of commercial interest due to their 
high percentage of nitrogen (6.89%) compared to synthetically substituted 
cellulose (1.25%). As most of the present-day polymers are synthetic materials, 
their biocompatibility and biodegradability are much more limited than those of 
natural polymers such as cellulose, chitin, chitosan and their derivatives. 
However, these naturally abundant materials also exhibit a limitation in their 
reactivity and processability [3, 4]. In this respect, chitin and chitosan are 
recommended as suitable functional materials, because these natural polymers 
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have excellent properties such as biocompatibility, biodegradability, non-toxicity 
and adsorption properties [5-7]. 
Chitin and chitosan derivatives are used in various fields [8, 9] treating water [10-
11], biomedical [12-19], cosmetic [19, 20], agricultural [21] or food industrial [22, 
23]. It shows some biological activities such as immunological [24], antibacterial 
[25], wound healing activity [26], drug delivery [27-30] and has been proposed for 
tissue engineering applications [31-33]. Chemical modification of chitin and 
chitosan to generate new biofunctional materials is of primary interest because 
such procedure would not change the fundamental skeleton of chitin and 
chitosan and would keep the original physicochemical and biochemical 
properties depending on the nature of the group introduced [7, 20, 26]. 
Introduction of groups such as phosphonic acid or phosphonate onto chitin and 
chitosan by reaction of phosphorylating agent onto the amino groups are known 
to increase the chelating properties [34-36] of chitin and chitosan and could 
modify its solubility. Several techniques to obtain phosphate derivatives of chitin 
and chitosan have been proposed due to the interesting biological and chemical 
properties of such compounds.   
A few review articles on the potential applications of chitin and chitosan for 
pharmaceutical, veterinary medicine, biomedical and environmental field have 
already been reported [10, 20, 23, 25, 37-42]. However, there is no 
comprehensive review about phosphorylated chitin and chitosan and its 
synthesis method and applications. This review intends to systematize related 
issues that include the various methods of preparation of phosphorylated chitin 
and chitosan. Moreover, the potential applications of phosphorylated chitin and 
chitosan in fields such as adsorbing metal ions, drug delivery, fuel cells, blood 
compatibility, food and tissue engineering are also discussed. The present review 
is an attempt to discuss the current applications and future prospects on the use 
of phosphorylated chitin and chitosan.  
 
Synthesis of phosphorylated chitin and chitosan 
The poor solubility of chitin and its derivatives in common solvents has been a 
major drawback to its utilization. Chemically modified chitin derivatives have 
good solubility in many solvents promoting the usefulness of this polysaccharide 
resource. Many efforts have been reported to prepare functional derivatives of 
chitin and chitosan by chemical modifications, in order to increase the solubility in 
water [43-47]. The reaction of chitin with phosphorous pentoxide was found to 
give water soluble phosphorylated chitin of high degree of substitution (DS). 
Phosphorylated chitin (P-chitin) and chitosan (P-chitosan) were prepared by 
heating chitin or chitosan with orthophosphoric acid and urea in DMF [48, 49, 50] 
(Fig. 1). 
P-chitin and P-chitosan were also prepared by the reaction of chitin or chitosan 
with phosphorous pentoxide in methanesulphonic acid [51, 52]. The 
phosphorylation reactions of chitin and chitosan in phosphorous pentoxide-
methane sulphonic acid were found to be a very efficient reaction [53-56]. 
Methanesulphonic acid worked as an efficient catalyst for the esterification 
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reaction. It was reported that DS of the products increased with increasing 
amount of phosphorous pentoxide, and the products became nearly fully 
phosphorylated with 4.0 mol. 
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Fig. 1. Synthesis of phosphorylated chitin and chitosan.  
 
However P-chitosan of high DS was insoluble in water while those of low DS 
were soluble. The insoluble character of P-chitosan of high DS may be attributed 
to the formation of inter- or intramolecular salt linkage between amino and 
phosphate groups due to the formation of poly-ion complex as generally seen in 
polyampholities. Nishi and co-workers [57] prepared P-chitin and P-chitosan by 
the cross-linking reaction with adipoyl chloride in methanesulphonic acid with 
phosphorous pentoxide for adsorbing metal ions. The cross-linking reaction was 
carried out with adipoyl chloride immediately after the reaction with phosphorous 
pentoxide without isolating P-chitin or P-chitosan. These products were 
completely insoluble in water, and were proposed to be used as adsorbents of 
metal ions in water.   
The synthesis of anionic, heteroatom containing carbohydrate polymers are of 
interest for a variety of reasons including the preparation of anticoagulants, 
metal-chelating agents, and fire-retardant materials. For these and other 
commercial uses, inexpensive methods are desirable to facilitate the 
incorporation of phosphorous containing residues into polysaccharides. The P-
chitin and P-chitosan were synthesized by mixing chitin or chitosan with sodium 
pyrophosphate [58]. P-chitosan was also synthesized by grafting mono(2-
methacryloyl oxyethyl)acid phosphate onto chitosan [59]. It was observed that 
the grafting reaction improved the antimicrobial activities of chitosan. It was also 
observed that the antimicrobial activity of chitosan and graft copolymer against 
Candida albicans, Trichophyton rubrum, and Trichophyton violaceum depends 
largely on the amount and type of grafted chains, as well as on the changes of 
pH [59].  
The incorporation of methylene phosphonic groups into chitosan allowed 
solubility in water under neutral conditions without decreasing its filmogenic 
properties [60]. A water soluble N-methylene phosphonic chitosan (NMPC) was 
synthesized using chitosan, phosphorous acid and formaldehyde [60] (Fig. 2). 
The introduction of the phosphonic acid function in the chitosan macromolecule 
via the Moedritzer and Irani [61] reaction is modified with phosphoric acid and 
formaldehyde yielding a chitosan derivative with different properties from 
chitosan. The viscosity of NMPC was practically independent o pH, and these 
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solutions at pH 6.8 became insoluble and precipitated as a white product. NMPC 
was prepared from chitosan with different acetylation degrees and time interval 
[62]. A significant decrease of viscosity and molecular weight was observed due 
to derivatization. The viscosity studies showed that, for 20 and 30 h reaction 
times a considerable decrease was observed. As a consequence of the 
phosphonomethylation, the crystallinity of the polymer was decreased drastically. 
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Fig. 2. Chemical structure of N-methylene phosphonic chitosan. 
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Fig. 3. Chemical structure of N-lauryl-N-methylene phosphonic chitosan (LMPC).  
 
N-lauryl carboxymethyl chitosan with both hydrophobic and hydrophilic groups 
was studied [63] in connection with delivery of taxol to cancerous tissues. Other 
examples are related to the production of polymeric vesicles for encapsulation of 
hydrophobic compounds like bleomycin [64]. NMPC offer the presence of 
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hydrophobic and hydrophilic branched for controlling solubility properties and 
leads to a new chitosan derivative surfactant. A simple methodology for the 
preparation of new chitosan derivative surfactant, N-lauryl-N-methylene 
phosphonic chitosan (LMPC), has been developed and reported [65] (Fig. 3). 
LMPC incorporated N-methylene phosphonic groups as hydrophilic moieties and 
lauryl groups as hydrophobic one. Therefore, LMPC derivatives open new 
perspectives in the pharmaceutical and the cosmetic fields. 
N-Phophonomethylation of chitosan reaction was studied and optimized using 
different reaction conditions [66]. The reaction was conducted with a large 
excess of both phosphorous acid and formaldehyde at 70 ºC. The obtained white 
solid is soluble in water and acidic solution. The NMR analysis showed that the 
side product is formed during the phosphonomethylation reaction of chitosan. 
The mechanism was proposed for its formation, based on the Leuckart-Wallach 
reaction [67-69].  The carboxymethylation of NMPC consisted in reacting with the 
free amino groups to yield a novel polyfunctional amine derivative. The 
multidendate soluble derivative has potential chelating ability not only for 
transitions metal ions but also for calcium ions [45, 35, 70-72].  
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Fig. 4. Chemical structure of N-methylene phosphonic N-methylene carboxylic 
chitosan (NMPCC).  
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Fig. 5. Synthesis of P-chitosan by grafting method.   
 
Ramos and co-workers [73] prepared N-methylene phosphonic and carboxylic 
chitosan (NMPCC) by using NMPC and glyoxallic acid (via aldimine formation) 
under reduction conditions with sodium borohydride. This new chitosan 
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multidentate ligand is carrying both carboxylic and phosphonic groups [73] (Fig. 
4). The films obtained from NMPCC were translucent, brilliant and mechanically 
resistant and had homogeneous appearance. The XRD studies showed NMPCC 
was amorphous in nature and also soluble in water. The crystallinity of Chitosan 
was decreased due to the phosphorylation. P-Chitosan was also synthesized by 
means of graft copolymerization [74]. 2-Carboxethylphosphonic acid was 
covalently grafted onto chitosan by using 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (EDC) mediated coupling reaction (Fig. 5).  
 
Applications of P- chitin and P-chitosan 
 
-Adsorbing metal ions 
The P-chitin and P-chitosan are found to be a strong metal-binding ability. It was 
found that their adsorption of uranium is much greater than of the other heavy 
metal ions [50, 75, 76]. P-chitin and P-chitosan were cross-linked with adipoyl 
chloride in methanesulphonic acid, and their metal binding ability to Mg2+, Ca2+, 
Sr2+, Ba2+, Mn2+, Ni2+, Cu2+, Zn2+ and Cd2+ was reported [57]. Conversion of chitin 
to insoluble P-chitin resulted in the increase of the binding ability to all metal ions 
and this was tested. The results indicated that the alkaline earth metals and Mn2+ 
were adsorbed strongly to these derivatives than to chitin or chitosan [57]. 
However, it was also found that the transition elements except Mn2+ were 
adsorbed strongly to chitosan than to these derivatives in their experimental 
condition. For the binding of Mg2+, Ca2+, Sr2+, Ba2+ and Mn2+, in which insoluble 
P-chitin or insoluble P-chitosan were superior in their metal-binding ability to 
chitin or chitosan, insoluble P-chitosan I (45% deacetylated) showed higher 
performanace than both insoluble P-chitin (less than 5% deacetylated) and 
insoluble P-chitosan II (97% deacetylated). These results indicated that half-
deacetylated derivatives among chitosan and P-chitosan present the highest 
metal-binding ability [57]. Ca2+ binding ability of insoluble P-chitin and P-chitosan 
were far larger than their starting materials in a wide pH range [57]. This would 
suggest the large contribution of the phosphoryl group to the Ca2+ binding. It also 
indicates that insoluble P-chitosan I show the highest binding ability in the 
studied pH. From these results, we concluded that the binding ability to alkaline 
earth metals was significantly enhanced by the introduction of phosphate group.  
Schwarzenbach et al [36] considered that the phosphonic complexing agents 
were as effective or even more than those containing carboxylic groups. The 
aminoalkylphosphonic ligands (NH2-CH2-PO32-) have well known strong chelating 
properties owing to the donor effect of the amine group (-NH2) and the 
monodentate ligand as –PO32- [34]. They have tendency to form chelates in ring 
structure with possibilities of different conformations owing to the metal ion 
nature. In the case of NMPC (NH2-CH2-PO32-) the presence of an amine group 
from chitosan combines these two effects, increasing the metal binding abilities 
[35]. One of the properties of NMPC is its ability to chelate not only transition-
metal ions, but also calcium ions [62]. From their results, the NMPC was a 
powerful chelating agent of transition metal and calcium ions.  
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Fuel cell applications 
The conductance measurements in P-chitosan were analyzed and reported [77]. 
P-chitosan membranes were almost non conductive in their dry states and 
hydrated membranes showed ionic conductive properties that can be one order 
of magnitude higher than unmodified chitosan membranes. Although crystallinity 
of P-chitosan membranes and the corresponding swelling index had changed 
pronouncedly, these membranes did not significantly lose their strength and 
thermal stability in comparison with unmodified chitosan membranes. From these 
results, P-chitosan membranes could have potential to be applied in alkaline 
polymer electrolyte fuel cells in the future. Yamada and Honma prepared an 
anhydrous proton-conducting membrane using a composite of P-chitin and the 
basic heterocycle imidazole (Im) [78]. A composite material of P-chitin and 200 
wt % Im showed a high proton conductivity of 7×10-3 Scm-1 at 150 ºC under 
anhydrous (water free) conditions. Additionally, the thermal stability of P-chitin/Im 
composite material was increased with the doping ratio of the imidazole. The 
utilization of a biopolymer such as P-chitin for polymer electrolyte membrane fuel 
cells technologies is novel, challenging, inexpensive, and environmentally 
benign. Application of these biopolymers in electrical devices would be attractive 
not only in the terms of product cost and environmental safety but also from a 
material science point of view. 
 
Drug delivery applications 
Chitosan based materials has been used in systems for the sustained release of 
drugs [23, 79, 80-84]. P-chitosan was used for the preparation of gel beads using 
TPP to improve the controlled release system in a gastrointestinal fluid [85]. This 
work included the in vitro drug release profiles monitored at various pH media at 
37 ºC using ibuprofen (Ib) as a model drug. The release percents of ibuprofen 
from P-chitosan gel beads were found to increase with increasing pH of the 
dissolution medium. This behavior indicated that the drug release profile is pH 
sensitive. The release rate of ibuprofen at pH 7.4 was noticeably higher than the 
release rate at pH 1.4 due to the ionization of phosphorous groups and high 
solubility of ibuprofen at pH 7.4 [86, 87] and also the electrostatic repulsion 
between negatively ionized carboxyl groups of Ib and phosphate groups in P-
chitosan molecules. The release rate in simulated intestinal fluid (pH 7.4) was 
higher than that in simulated gastric fluid (pH 1.4), enabling the drug delivery or 
release to take place preferentially in the intestine with avoiding simultaneously 
the drug leakage in the stomach. All of these interesting features indicated that 
the PCS gel beads could be used as successful drug carrier for controlled drug 
delivery in oral administration.  
Win and co-workers investigated the effect of proteolytic enzymes on the in vitro 
release of Ib from P-chitosan in microspheres in simulated gastric fluid (SGF) (pH 
1.4) and simulated intestinal fluid (SIF) (pH 7.4) [88]. To reduce the enzymatic 
degradability and to enhance the sustained release property, polyelectrolyte 
complex microspheres based on P-chitosan by using TPP were developed and 
characterized. The Ib released from P-chitosan microspheres sustained more 
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effectively than that from CS microspheres in the medium of proteolytic enzymes 
such as pepsin and trypsin, respectively. These P-chitosan microspheres could 
serve as a good candidate for oral drug-delivery systems with sustained release 
properties due to their higher stability in SGF and SIF containing hydrolytic 
enzymes. Similarly, P-Chitosan beads were also synthesized by using TPP with 
indomethacin drug and the in vitro drug releases were carried out at different pHs 
[74]. The release rate of indomethacin at pH 7.4 was higher than that at pH 1.4, 
due to the ionization of phosphorous groups and high solubility of indomethacin 
in the alkaline medium. These results indicated that PCTS beads have potential 
to be used as controlled drug delivery systems through oral administration since 
the drug release in the highly acidic gastric fluid region of the stomach is avoided. 
 
Food applications 
NMPC and LMPC are being studied as a result of their broad range of food 
applications. These biopolymers offer a wide range of unique applications 
including formation of biodegradable films, immobilization of enzymes, 
preservation of food from microbial deterioration, as additives (clarification and 
deacidification of fruits and beverages, emulsifying agents, thickening and 
stabilizing agents, color stabilization), and dietary supplements. The introduction 
of phosphonic groups into chitosan provided water solubility and potential 
chelating and emulsifying abilities in food applications [62].  
 
Tissue engineering and other biomedical applications 
Tissue engineering has emerged as a new area of regenerative medicine, with 
the capability of surpassing some of the disadvantage of using pure synthetic 
materials, in conventional replacement procedures. The common concepts 
associated in the tissue engineering research are based on the construction of 
hybrid materials obtained from the incorporation of cells (and other biological 
agents such as growth factors) into a 3D porous scaffold or hydrogel. The 
scaffold material has an essential function concerning cell anchorage, 
proliferation and tissue formation in three dimensions. The material should be 
able to process into porous scaffold structures, with the porosity characteristics 
being application specific. Recently, chitosan and its derivatives have been 
reported as attractive candidates for scaffolding materials because it is expected 
that they degrade as the new tissues is being formed, eventually without 
inflammatory reactions or toxic degradation [25, 89, 90].  
Calcium-phosphate based-bioceramics, in the form of powder, granules and 
coatings are currently used in for a number of dental and skeletal prosthetic 
applications by virtue of their excellent biocompatibility and osteointegration 
process [91]. Recently, calcium phosphate materials are being grown 
biomimetically over different surface-modified substrates in order to gain insight 
into how to develop biomaterials with tailored surface properties that can initiate 
calcium phosphate deposition when implanted at bony sites [92-94]. The 
nucleation or precipitation of hydroxyapatite over different material surfaces can 
be achieved by either (a) raising the ionic activity product of calcium phosphate in 
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the solution, thereby stimulating precipitation and creation of apatite nucleation 
sites [95] or by a (b) surface functionalization method, used to create favorable 
local conditions that lead to the nucleation and growth of calcium phosphate [96-
98]. These techniques are mainly based on functionalization and subsequent 
immersion of the substrate material in simulated body fluid solution (SBF). 
Phosphate group as functionalization radical was found to be very effective for 
the deposition of hydroxyapatite over cotton, chitin [97, 98]. Prior to immersion in 
SBF, the phosphorylated substrate is subjected to soaking in saturated Ca(OH)2 
solution. This treatment creates a number of calcium precursor sites over the 
surface that will eventually create favorable condition for the nucleation and 
growth of HAP. 
Calcium phosphate growth on P-chitin fibers and P-chitosan films were studied 
[98, 99]. Chitin fibres of P-Chitosan films were soaked in saturated Ca(OH)2 
solution at ambient temperature. It is believed that the thin coatings of calcium 
phosphate material on the fibers produced by partial hydrolysis of the chitin PO4 
functionalities during soaking in saturated Ca(OH)2 solution acted as a nucleation 
layer upon which the calcium phosphate can grow from the SBF solution. In 
general, the growth of calcium phosphate from SBF begins immediately after 1 
day of soaking. This suggested that clusters have partially dissolved upon 
introduction of the chitin and chitosan into the SBF solution. The growth of 
calcium phosphate layer after soaking for 1-6 days appears to proceed by 
nucleation on the existing coating in the form of circular flakes, which then grow 
in number and size on the surface. After soaking for 9-17 days, the thicker 
coating was observed. The P-chitin fiber and P-chitosan films which were not 
subjected to the Ca(OH)2 treatment did not exhibit calcium phosphate growth 
upon immersion in SBF. During the Ca(OH)2 treatment, a calcium phosphate 
precursor phase is expected to be formed all over the chitosan surface which will 
initiate calcium-deficient HAP growth on subsequent immersion in SBF solution.  
Chitin/chitosan-calcium phosphate systems have potential to be used as virus 
filters, given the adsorptive properties of hydroxyapatite [100-101] which may 
allow the attachment of drugs for treatment of viral diseases. The biocompatibility 
of the samples was evaluated by cell culture test using L-929 cells and better 
results were obtained in the coated sheets. Recent approaches towards the 
development of chitin as a hard tissue substitute material take into consideration 
the interaction of chitin with calcium phosphate. Cumulative research in the field 
of bone repair has introduced concepts, which relate the bioactivity of a material 
to its calcification properties [102]. Surfaces, which can induce the formation of 
an apatite layer in vitro, or if it is coated with an apatite layer, may demonstrate, 
improved bone-binding properties [103]. A material with the propensity to clarify 
in vivo also encourages post-operative formation of calcium phosphate phases 
[104]. In addition, favorable interactions between the implant material and 
calcium phosphate will also ensure in vivo stability of the particular calcium 
phosphate coating [105]. Extensive studies investigating the influence of various 
factors on the crystallization of calcium phosphate have been performed since 
the 1950s. Most of these studies were focused towards uncovering the role of 
various acidic proteins of the human bone matrix [106, 107]. Many of the factors 
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in the soluble state displayed an inhibitory effect towards calcium phosphate 
formation while others promoted mineralization [108-111]. The potential of chitin-
based materials as a bone substitute material for orthopedic applications 
warrants the need to study the influence of their acidic derivatives on both 
heterogeneous and homogeneous calcium phosphate precipitation and 
crystallization [112]. 
The influence of two-water soluble anionic derivatives, sodium carboxymethyl-
chitin (CM-chitin) and P-chitin on the crystallization of calcium phosphate by 
seeded growth and turbidity were studied [113]. The results showed that the CM-
chitin exerted only a slight but noticeable effect on hydroxyapatite seeded 
growth. In contrast, P-chitin appears to demonstrate a very potent inhibitory 
effect. The behavior of P-chitin is similar to phosphoserine and 
phosphatidylserine where pronounced inhibitory effects on hydroxyapatite 
seeded growth were found [114, 115]. Macroporous scaffolds were obtained 
through a freeze-drying technique using both NMPC and CS [116]. Biomimetic 
mineralization was carried out in different media, i.e., SBF or CaCl2 and 
Na2HPO4 solutions [116]. NMPC with phosphonic groups led to clear differences 
in the ability of scaffold wall surface to support heterogeneous calcium phosphate 
nucleation and growth. CS scaffold incubated in SBF for 20 days did not display 
mineral growth, whereas NMPC scaffold showed increasing mineral particulates, 
surface coverage with an essential continuous mineral layer. The 
biomineralization behavior of NMPC was superior to that of CS at higher soaking 
cycle number. Moreover, these scaffolds only deposit apatite slightly in SBF. This 
result provided NMPC derivatives constituting biocomposite scaffold with 
improved compressive stiffness. Similarly, it has been reported calcium 
phosphate mineral was formed on P-chitosan membranes after soaking with 
Ca(OH)2 [117].  
Large bone and skeletal repair are always a tough problem of surgeons in clinics. 
The natural biological materials for bone defect repair, including autografts and 
allografts, each has its own shortcomings such as donor site morbidity and donar 
shortage for autografts [118], immunologic response and endothermic risk for 
allografts [119]. Although numerous synthetic bone substitutes using metals, 
ceramics, and polymers have been developed to promote bone regeneration for 
several decades, there exists a lack of confidence in their biological 
performances, particularly in view of long term, in vivo safety and efficiency [120]. 
For example, metals are difficult to shape and have a problem of corrosion, 
which leads to inflammatory responses of surrounding tissue [121, 122]. 
Polymers are usually encapsulated and do not integrate with tissue, resulting in 
implant movement, inflammatory responses, and implant extrusion [121, 123]. 
Ceramics are fragile and difficult to sculpt to skeletal defects [120, 124, 125]. 
Recently, much attention has been paid to calcium phosphate cements (CPCs), 
for their highly osteoconductivity, readily osteointegrated, easily shaped (injected) 
and gradually degradable properties [126, 127]. However, when compared with 
natural bone, the lack of toughness and binding ability are still their undesired 
properties. So, some researchers added water-soluble polymers such as sodium 
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aliginate [128], hydroxypropyl methylcellulose and carboxymethylcellulose [129] 
into tetracalcium phosphate (TTCP) containing cements to improve the handling 
properties. The water-soluble P-chitosans that could be quickly biodegraded by 
lysozyme in vivo was prepared and mixed with two easily prepared CPCs [130, 
131]. Monocalcium phosphate monohydrate (MPCM) with calcium oxide (CaO) in 
1 M phosphate buffer (CPC-I) and dicalcium phosphate dehydrate (DCPD) with 
calcium hydroxide [Ca(OH)2] in 1 M Na2HPO4 solution (CPC-II). With certain 
amount of P-chitosan, the resulted P-chitosan containing CPCs (P-CPCs) have 
high mechanical strength and slightly prolonged setting time. In vitro experiments 
have shown that P-chitosan can increase the dissolubility of the start materials of 
cements and bind calcium phosphate strongly afterwards [132]. Since slight 
difference in CPC compositions may lead a considerable change of clinical 
result, further animal tests of the CPC and P-CPCs in radial and tibial defects of 
rabbits were performed [132]. The biocompatible, bioabsorabable and 
osteoinductive properties were evaluated. No osteolysis, hyperplasia or other 
negative responses were found in the CPC and P-CPC containing samples 
through the study of 22 weeks. Histological examination has also revealed that 
bone repair in the P-CPCs showed full different manner with CPC, in which 
microphages appeared around implants. The biodegradation rate of the implants 
was found to depend on the P-chitosan content: and the samples with more 
content of P-chitosan showed the slower degradation rate. Thus, for the rapid 
repair of no loading bone, the low P-chitosan samples should be chosen rather 
than the P-chitosan samples. High P-chitosan samples may have special use in 
high loading bone-defect repair. Similarly, the effects of P-chitin in the tissue 
responses to two CPCs were investigated using a rabbit model [133].  
As indicated by Ripamonti and Duneas [134], an ideal biomaterial for bone tissue 
engineering should be non-immunogenic, biodegradable, highly effective in 
osteoinduction with relatively low doses of inducing signals, ready for rapid 
vascular and mesenchymal cell invasion, carvable, and amenable to contouring 
for optimal adaptation to the various shapes of bone defects, providing 
mechanical support when needed. The P-CPCs fulfilled all of those requirements 
and can be considered promising materials for bone repair. Cell response of rat 
osteoblasts and fibroblasts to water-soluble P-chitin and P-chitosan on the 
functions was examined in vitro [135, 136]. The cell morphology was observed at 
1, 4 and 7 days respectively together with other biological tests. The results 
suggested that P-chitin and P-chitosan has no toxicity on both cell lines. The 
stimulatory effect of P-chitin and P-chitosan may be due to the additional PO3= 
groups in molecules and could be promising biomaterials for tissue engineering. 
 
Conclusions 
In this review, we have presented different synthesis methods of P-chitin and 
chitosan and their general features. Phosphorylation of chitin and chitosan have 
improved their solubility, antibacterial, chelating and ionic conductive properties.  
Due to these favorable properties these materials have a wide range of 
applications in the biometerial field. This review also summarized some of the 
recent applications of these materials in various fields such as adsorbing metal 
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ions, fuel cell, drug delivery, food processing and tissue engineering. Within their 
more promissory usage, P-chitin and P-chitosans can be processed into porous 
structures for tissue engineering scaffolding. As a result, these polymers would 
have potential to be applied in cell transplantation and tissue regeneration 
methodologies. The high sorption capacities of modified P-chitin and chitosan for 
metal ions can be of great advantage for the recovery of valuable metals or the 
treatment of contaminated effluents.  
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